Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
Nuvectis Pharma | DEFA14A: Others
Nuvectis Pharma | DEF 14A: Definitive information statements
Nuvectis Pharma | 8-K: Current report
Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
Nuvectis Pharma | 8-K: Current report
Nuvectis Pharma | 8-K: Current report
Nuvectis Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports Second Quarter 2023 Financial Results and Business Highlights
Nuvectis Pharma | 8-K: Current report
Nuvectis Pharma | 8-K: Current report
Nuvectis Pharma | 8-K: Current report
Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports First Quarter 2023 Financial Results and Business Highlights
Nuvectis Pharma | DEF 14A: Definitive proxy statements
Nuvectis Pharma | S-3: Registration statement for specified transactions by certain issuers
Nuvectis Pharma | 8-K: Current report
Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports Third Quarter 2022 Financial Results and Business Highlights
Nuvectis Pharma | S-1: General form for registration of securities under the Securities Act of 1933
Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports Second Quarter 2022 Financial Results and Business Highlights
Nuvectis Pharma | 8-K: Current report
No Data